Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors.

@article{Kishi1977BioenergeticsIC,
  title={Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors.},
  author={Takeo Kishi and Takashi Watanabe and Karl Folkers},
  journal={Research communications in chemical pathology and pharmacology},
  year={1977},
  volume={17 1},
  pages={157-64}
}
Adrenergic blockers for beta-receptors were studied for inhibition of mitochrondrial CoQ10-enzymes. These enzymes are indispensable for the bioenegetics of the myocardium. Propranolol is frequently used to treat hypertension; in some patients, it depresses myocardial function as an adverse reaction. This side effect may be related to the inhibition by… CONTINUE READING